Current roles
From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.
No current S&P 500 role.
Past roles
“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.
Sits alongside
People who currently share a board or management team with this person.
No current colleagues on record.
Open-market trades
Purchases and sales reported on Form 4 at S&P 500 companies.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 28, 2022 | MRNA | Sale | 2,000 | $180.00 | $360K |
| Dec 21, 2022 | MRNA | Sale | 2,000 | $201.70 | $403K |
| Dec 14, 2022 | MRNA | Sale | 2,000 | $195.00 | $390K |
| Dec 7, 2022 | MRNA | Sale | 2,000 | $172.16 | $344K |
| Nov 30, 2022 | MRNA | Sale | 2,000 | $173.52 | $347K |
| Nov 29, 2022 | MRNA | Sale | 814 | $173.80 | $141K |
| Nov 23, 2022 | MRNA | Sale | 2,000 | $178.01 | $356K |
| Nov 16, 2022 | MRNA | Sale | 2,000 | $184.25 | $369K |
| Nov 10, 2022 | MRNA | Sale | 192 | $165.59 | $32K |
| Nov 9, 2022 | MRNA | Sale | 2,000 | $162.50 | $325K |
| Nov 2, 2022 | MRNA | Sale | 2,000 | $154.20 | $308K |
| Oct 28, 2022 | MRNA | Sale | 4,000 | $150.00 | $600K |
| Aug 29, 2022 | MRNA | Sale | 839 | $135.81 | $114K |
| Aug 17, 2022 | MRNA | Sale | 2,000 | $165.24 | $330K |
| Aug 10, 2022 | MRNA | Sale | 2,000 | $174.09 | $348K |
| Aug 10, 2022 | MRNA | Sale | 204 | $173.66 | $35K |
| Aug 3, 2022 | MRNA | Sale | 2,000 | $167.99 | $336K |
| Jul 27, 2022 | MRNA | Sale | 2,000 | $161.00 | $322K |
| Jul 20, 2022 | MRNA | Sale | 2,000 | $167.00 | $334K |
| Jul 13, 2022 | MRNA | Sale | 2,000 | $168.88 | $338K |
| Jul 6, 2022 | MRNA | Sale | 2,000 | $154.85 | $310K |
| Jul 1, 2022 | MRNA | Sale | 6,000 | $150.00 | $900K |
| Jun 8, 2022 | MRNA | Sale | 10,000 | $150.00 | $1.5M |
| May 31, 2022 | MRNA | Sale | 749 | $145.40 | $109K |
| May 10, 2022 | MRNA | Sale | 195 | $133.71 | $26K |
| May 4, 2022 | MRNA | Sale | 2,000 | $153.23 | $306K |
| Apr 29, 2022 | MRNA | Sale | 2,000 | $150.00 | $300K |
| Apr 20, 2022 | MRNA | Sale | 2,000 | $153.00 | $306K |
| Apr 13, 2022 | MRNA | Sale | 2,000 | $158.37 | $317K |
| Apr 6, 2022 | MRNA | Sale | 2,000 | $157.50 | $315K |
| Mar 30, 2022 | MRNA | Sale | 2,000 | $182.79 | $366K |
| Mar 23, 2022 | MRNA | Sale | 2,000 | $184.66 | $369K |
| Mar 16, 2022 | MRNA | Sale | 2,000 | $150.01 | $300K |
| Mar 14, 2022 | MRNA | Sale | 2,000 | $150.00 | $300K |
| Mar 2, 2022 | MRNA | Sale | 2,000 | $150.00 | $300K |
| Mar 1, 2022 | MRNA | Sale | 6,365 | $152.53 | $971K |
| Feb 24, 2022 | MRNA | Sale | 2,000 | $150.00 | $300K |
| Feb 16, 2022 | MRNA | Sale | 2,000 | $150.00 | $300K |
| Feb 10, 2022 | MRNA | Sale | 768 | $158.89 | $122K |
| Feb 9, 2022 | MRNA | Sale | 2,000 | $154.26 | $309K |
| Feb 2, 2022 | MRNA | Sale | 2,000 | $170.89 | $342K |
| Dec 31, 2021 | MRNA | Sale | 5,000 | $249.88 | $1.2M |
| Dec 29, 2021 | MRNA | Sale | 5,000 | $240.00 | $1.2M |
| Dec 27, 2021 | MRNA | Sale | 10,000 | $243.10 | $2.4M |
| Dec 22, 2021 | MRNA | Sale | 5,000 | $264.26 | $1.3M |
| Dec 20, 2021 | MRNA | Sale | 15,000 | $320.97 | $4.8M |
| Dec 17, 2021 | MRNA | Sale | 5,000 | $275.68 | $1.4M |
| Dec 15, 2021 | MRNA | Sale | 5,000 | $272.11 | $1.4M |
| Dec 13, 2021 | MRNA | Sale | 5,000 | $257.01 | $1.3M |
| Dec 10, 2021 | MRNA | Sale | 5,000 | $235.00 | $1.2M |
| Dec 8, 2021 | MRNA | Sale | 5,000 | $282.35 | $1.4M |
| Dec 6, 2021 | MRNA | Sale | 15,000 | $280.60 | $4.2M |
| Dec 3, 2021 | MRNA | Sale | 5,000 | $318.40 | $1.6M |
| Dec 1, 2021 | MRNA | Sale | 5,000 | $329.91 | $1.6M |
| Nov 29, 2021 | MRNA | Sale | 5,000 | $370.38 | $1.9M |
| Nov 26, 2021 | MRNA | Sale | 5,000 | $319.62 | $1.6M |
| Nov 24, 2021 | MRNA | Sale | 5,000 | $273.01 | $1.4M |
| Nov 22, 2021 | MRNA | Sale | 15,000 | $268.18 | $4.0M |
| Nov 19, 2021 | MRNA | Sale | 5,000 | $265.71 | $1.3M |
| Nov 17, 2021 | MRNA | Sale | 5,000 | $234.57 | $1.2M |
| Nov 15, 2021 | MRNA | Sale | 5,000 | $231.01 | $1.2M |
| Nov 12, 2021 | MRNA | Sale | 5,000 | $225.86 | $1.1M |
| Nov 10, 2021 | MRNA | Sale | 5,000 | $230.00 | $1.1M |
| Nov 8, 2021 | MRNA | Sale | 15,000 | $233.13 | $3.5M |
| Nov 5, 2021 | MRNA | Sale | 5,000 | $240.00 | $1.2M |
| Nov 3, 2021 | MRNA | Sale | 5,000 | $350.00 | $1.8M |
| Nov 1, 2021 | MRNA | Sale | 5,000 | $335.00 | $1.7M |
| Oct 29, 2021 | MRNA | Sale | 5,000 | $344.49 | $1.7M |
| Oct 27, 2021 | MRNA | Sale | 5,000 | $344.25 | $1.7M |
| Oct 25, 2021 | MRNA | Sale | 15,000 | $327.36 | $4.9M |
| Oct 22, 2021 | MRNA | Sale | 5,000 | $333.00 | $1.7M |
| Oct 20, 2021 | MRNA | Sale | 5,000 | $333.90 | $1.7M |
| Oct 18, 2021 | MRNA | Sale | 5,000 | $322.26 | $1.6M |
| Oct 15, 2021 | MRNA | Sale | 5,000 | $341.25 | $1.7M |
| Oct 13, 2021 | MRNA | Sale | 5,000 | $314.90 | $1.6M |
| Oct 11, 2021 | MRNA | Sale | 15,000 | $300.00 | $4.5M |
| Oct 8, 2021 | MRNA | Sale | 5,000 | $310.44 | $1.6M |
| Oct 6, 2021 | MRNA | Sale | 5,000 | $318.23 | $1.6M |
| Oct 4, 2021 | MRNA | Sale | 5,000 | $307.54 | $1.5M |
| Oct 1, 2021 | MRNA | Sale | 5,000 | $359.00 | $1.8M |
| Sep 29, 2021 | MRNA | Sale | 5,000 | $393.44 | $2.0M |
| Sep 27, 2021 | MRNA | Sale | 15,000 | $429.38 | $6.4M |
| Sep 24, 2021 | MRNA | Sale | 5,000 | $448.04 | $2.2M |
| Sep 22, 2021 | MRNA | Sale | 5,000 | $433.00 | $2.2M |
| Sep 20, 2021 | MRNA | Sale | 5,000 | $417.62 | $2.1M |
| Sep 17, 2021 | MRNA | Sale | 5,000 | $438.24 | $2.2M |
| Sep 15, 2021 | MRNA | Sale | 5,000 | $427.13 | $2.1M |
| Sep 13, 2021 | MRNA | Sale | 15,000 | $447.41 | $6.7M |
| Sep 10, 2021 | MRNA | Sale | 5,000 | $461.85 | $2.3M |
| Sep 8, 2021 | MRNA | Sale | 5,000 | $433.72 | $2.2M |
| Sep 7, 2021 | MRNA | Sale | 5,000 | $409.59 | $2.0M |
| Sep 3, 2021 | MRNA | Sale | 5,000 | $392.35 | $2.0M |
| Sep 1, 2021 | MRNA | Sale | 5,000 | $381.82 | $1.9M |
| Aug 30, 2021 | MRNA | Sale | 15,000 | $368.93 | $5.5M |
| Aug 27, 2021 | MRNA | Sale | 5,000 | $398.12 | $2.0M |
| Aug 25, 2021 | MRNA | Sale | 5,000 | $391.59 | $2.0M |
| Aug 23, 2021 | MRNA | Sale | 5,000 | $390.11 | $2.0M |
| Aug 20, 2021 | MRNA | Sale | 5,000 | $374.88 | $1.9M |
| Aug 18, 2021 | MRNA | Sale | 5,000 | $407.00 | $2.0M |
| Aug 16, 2021 | MRNA | Sale | 15,000 | $379.27 | $5.7M |
SEC reporting-owner ID (CIK) 1760670 · all filings on EDGAR